A recent study identified CRYAB as part of a gene cluster associated with good prognosis despite its significant association with the clinical-pathological parameters of ER−/PR− and HER2− (Buttacavoli et al. 2021), a breast cancer patient group with poor prognosis (Parker et al. 2009). The gene discussed is ESR1; the disease is breast carcinoma.